Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 30, 2010
In patients younger than age 55 years with lymph node-negative breast cancer, proliferation by mitotic activity index is prognostically superior to adjuvant!
Tone Hoel Lende, Emiel A M Janssen, Einar Gudlaugsson, et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists
|
April 30, 2013
Prognostic comparison of the proliferation markers (mitotic activity index, phosphohistone H3, Ki67), steroid receptors, HER2, high molecular weight cytokeratins and classical prognostic factors in T₁₋₂N₀M₀ breast cancer
Einar Gudlaugsson, Jan Klos, Ivar Skaland, et al.
Molecular Oncology
|
January 5, 2016
Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer
Kjersti Tjensvoll, Morten Lapin, Tove Buhl, et al.
International Journal of Colorectal Disease
|
May 17, 2011
Heterogeneous distribution of K-ras mutations in primary colon carcinomas: implications for EGFR-directed therapy
Satu Oltedal, Ole Gunnar Aasprong, Jannicke H Møller, et al.
BMC Surgery
|
August 27, 2017
Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) - study protocol for a national multicentre randomized controlled trial
Knut Jørgen Labori, Kristoffer Lassen, Dag Hoem, et al.
BMC Cancer
|
June 6, 2022
Prognostic value of disseminated tumor cells in unresectable pancreatic ductal adenocarcinoma: a prospective observational study
Oddmund Nordgård, Morten Lapin, Kjersti Tjensvoll, et al.
Journal of Biological Rhythms
|
April 19, 2007
Circadian variations in clock gene expression of human bone marrow CD34+ cells
Oleg Tsinkalovsky, Rune Smaaland, Benedikte Rosenlund, et al.
Journal of Translational Medicine
|
November 8, 2018
Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
Morten Lapin, Satu Oltedal, Kjersti Tjensvoll, et al.
Molecular Medicine (Cambridge, Mass.)
|
August 28, 2013
Influence of microsatellite instability and KRAS and BRAF mutations on lymph node harvest in stage I-III colon cancers
Marianne Berg, Marianne Guriby, Oddmund Nordgård, et al.
Breast Cancer Research and Treatment
|
July 10, 2012
The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer
Kristin Jonsdottir, Hui Zhang, Darshni Jhagroe, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 30, 2010
In patients younger than age 55 years with lymph node-negative breast cancer, proliferation by mitotic activity index is prognostically superior to adjuvant!
Tone Hoel Lende, Emiel A M Janssen, Einar Gudlaugsson, et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists
|
April 30, 2013
Prognostic comparison of the proliferation markers (mitotic activity index, phosphohistone H3, Ki67), steroid receptors, HER2, high molecular weight cytokeratins and classical prognostic factors in T₁₋₂N₀M₀ breast cancer
Einar Gudlaugsson, Jan Klos, Ivar Skaland, et al.
Molecular Oncology
|
January 5, 2016
Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer
Kjersti Tjensvoll, Morten Lapin, Tove Buhl, et al.
International Journal of Colorectal Disease
|
May 17, 2011
Heterogeneous distribution of K-ras mutations in primary colon carcinomas: implications for EGFR-directed therapy
Satu Oltedal, Ole Gunnar Aasprong, Jannicke H Møller, et al.
BMC Surgery
|
August 27, 2017
Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) - study protocol for a national multicentre randomized controlled trial
Knut Jørgen Labori, Kristoffer Lassen, Dag Hoem, et al.
BMC Cancer
|
June 6, 2022
Prognostic value of disseminated tumor cells in unresectable pancreatic ductal adenocarcinoma: a prospective observational study
Oddmund Nordgård, Morten Lapin, Kjersti Tjensvoll, et al.
Journal of Biological Rhythms
|
April 19, 2007
Circadian variations in clock gene expression of human bone marrow CD34+ cells
Oleg Tsinkalovsky, Rune Smaaland, Benedikte Rosenlund, et al.
Journal of Translational Medicine
|
November 8, 2018
Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
Morten Lapin, Satu Oltedal, Kjersti Tjensvoll, et al.
Molecular Medicine (Cambridge, Mass.)
|
August 28, 2013
Influence of microsatellite instability and KRAS and BRAF mutations on lymph node harvest in stage I-III colon cancers
Marianne Berg, Marianne Guriby, Oddmund Nordgård, et al.
Breast Cancer Research and Treatment
|
July 10, 2012
The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer
Kristin Jonsdottir, Hui Zhang, Darshni Jhagroe, et al.
Page
of 4